sepsi
sever
sepsi
septic
shock
repres
continuum
clinic
syndrom
common
complic
observ
patient
infect
trauma
major
surgeri
syndrom
start
infect
induc
system
inflammatori
respons
syndrom
sir
evolv
sepsi
induc
acut
organ
dysfunct
cardiovascular
collaps
epidemiolog
studi
demonstr
sever
sepsi
popul
preval
unit
state
count
intens
care
unit
icu
patient
sever
sepsi
alreadi
acknowledg
first
caus
death
noncoronari
icu
high
mortal
rate
approxim
past
one
two
decad
steadi
progress
treatment
sepsi
made
due
advanc
support
care
icu
implement
bundl
therapi
howev
search
specif
remedi
reliabl
predictor
within
pathophysiolog
mechan
sepsi
still
emphasi
today
studi
defensin
classifi
subfamili
cation
antimicrobi
peptid
major
compon
human
innat
immun
small
endogen
peptid
three
disulphid
bond
creat
six
cystein
residu
defensin
categor
three
subtyp
base
spatial
structur
locat
three
disulphid
bond
within
peptid
past
decad
cumul
evid
suggest
defensin
play
import
role
may
potenti
intervent
target
sepsi
review
herebi
summar
vitro
vivo
genet
studi
defensin
effect
well
correspond
mechan
within
sepsi
sequenti
syndrom
defensin
broad
spectrum
antimicrobi
activ
pathogen
sepsi
constitut
express
human
neutrophil
human
neutrophil
peptid
hnp
intestin
paneth
cell
human
defensin
hd
inhibit
larg
varieti
gramposit
bacteria
gramneg
bacteria
speci
fungi
virus
mainli
distribut
epitheli
cell
respiratori
system
digest
system
genitourinari
system
effect
kill
number
gramneg
bacteria
e
coli
p
aeruginosa
gramposit
bacteria
aureu
streptococcu
pyogen
candida
albican
even
bactericid
effect
toward
multiresist
aureu
vancomycinresist
enterococcu
uniqu
macrocycl
structur
isol
leukocyt
speci
monkey
detect
human
also
report
antimicrobi
activ
spectrum
pathogen
includ
e
coli
aureu
c
albican
also
found
protect
effect
mous
model
lethal
pulmonari
infect
mous
adapt
strain
sarscoronaviru
classic
mechan
defensin
bactericid
effect
pore
format
theori
posit
charg
antimicrobi
peptid
target
neg
charg
bacteri
membran
compon
lipopolysaccharid
teichoic
acid
phospholipid
form
transmembran
pore
disrupt
cell
integr
lead
bacteria
lysi
recent
anoth
mechan
report
defensin
kill
bacteria
inhibit
synthesi
bacteri
cell
wall
interact
certain
precursor
lipid
ii
defensin
bactericid
effect
limit
high
salt
concentr
local
environ
encount
pathogen
also
antimicrobi
action
appear
regul
redox
respons
becom
potent
reduct
disulfid
bridg
thioredoxin
reduc
environ
defensin
also
report
modul
effect
innat
adapt
immun
respons
well
known
particip
host
immun
defens
via
multipl
mechan
includ
enhanc
macrophag
phagocytosi
facilit
neutrophil
recruit
modul
complement
activ
chemoattract
immatur
cell
dendrit
cell
vitro
studi
show
potent
chemotact
effect
lead
recruit
matur
naiv
dendrit
cell
memori
cell
inflammatori
site
trigger
specif
immun
respons
host
endogen
ligand
interact
immun
cell
regul
express
inflammatori
mediat
via
pathway
vivo
research
reveal
abnorm
express
associ
sepsi
variou
infecti
diseas
level
plasma
bronchoalveolar
lavag
fluid
patient
pulmonari
infect
elev
transcript
leukocyt
sever
septic
patient
suppress
express
burn
wound
reduc
impair
express
associ
inflammatori
bowel
diseas
mous
model
acut
lung
injuri
shu
et
al
express
recombin
lung
tissu
via
recombin
adenoviru
studi
protect
effect
p
aeruginosa
infect
compar
control
mice
found
consider
less
p
aeruginosa
transinfect
lung
tissu
well
allevi
alveolar
impair
interstiti
edema
neutrophil
infiltr
subsequ
studi
mice
transinfect
adenoviru
without
gene
receiv
cecal
ligat
punctur
clp
twice
gener
sepsi
model
impact
inflammatori
respons
eg
level
express
sever
lung
injuri
sepsi
outcom
surviv
rate
observ
evalu
found
recombin
could
downregul
express
lung
tissu
h
h
h
clp
significantli
rais
surviv
rate
sepsi
mice
clinic
set
olbrich
et
al
found
preterm
neonat
lower
level
cord
blood
compar
term
neonat
among
preterm
neonat
lower
level
associ
lateonset
sepsi
studi
indic
may
play
import
role
immun
inflammatori
respons
sepsi
might
influenc
outcom
sepsi
among
rhesu
macaqu
rtd
six
subtyp
extens
studi
though
express
human
rtd
report
significantli
reduc
level
human
peripher
blood
leukocyt
preincub
variou
tolllik
receptor
agonist
furthermor
vivo
studi
show
subcutan
administr
mgkg
could
improv
surviv
rate
suppress
level
number
inflammatori
cytokin
chemokin
two
sepsi
mous
model
receiv
either
intraperiton
inject
e
coli
clp
although
detail
mechan
protect
effect
illumin
author
suggest
interact
leukocyt
critic
determin
blockad
latter
major
proinflammatori
cytokin
influenc
consequ
inflammatori
cascad
result
indic
may
potenti
immun
adjuv
treatment
sepsi
though
express
human
sepsi
inflammatori
disord
defensin
among
group
rapidlyreleas
host
endogen
molecul
capabl
recruit
activ
apc
also
term
alarmin
recent
vitro
studi
shown
alarmin
abil
boost
host
inflammatori
respons
promot
macrophag
product
pyroptosi
via
purinerg
receptor
howev
effect
doubleedg
sword
sepsi
sinc
promot
pathogen
elimin
well
mediat
organ
dysfunct
acut
lung
injuri
molecular
genet
molecular
biolog
knockout
anim
model
one
convinc
mean
determin
role
specif
molecul
physiopatholog
certain
diseas
howev
member
defensin
famili
overlap
biolog
function
function
knockout
gene
anim
model
may
probabl
compens
defensin
sinc
gene
cluster
code
entir
defensin
famili
fulli
knock
use
present
techniqu
molecular
biolog
genet
well
human
defensin
lack
absolut
anim
analogu
genet
associ
analysi
good
altern
effect
explor
relationship
genet
polymorph
sepsi
normal
peripher
blood
cell
mrna
level
rais
remark
stimul
lp
p
aeruginosa
howev
upregul
vari
among
individu
result
interindividu
differ
host
defens
capac
henc
influenc
clinic
progress
sepsi
previou
studi
show
singl
nucleotid
polymorph
snp
gene
correl
chronic
obstruct
pulmonari
diseas
asthma
genet
allergi
hiv
infect
pseudomona
speci
infect
oral
mucosa
sinc
sepsi
multifactori
diseas
caus
environment
factor
pathogen
microb
host
factor
comorbid
genet
background
occurr
outcom
influenc
individu
genet
background
chen
et
al
select
snp
promot
region
one
extron
candid
loci
studi
patient
sever
sepsi
healthi
control
distribut
allel
gene
type
haplotyp
associ
loci
studi
compar
septic
patient
control
well
surviv
victim
sever
sepsi
associ
analysi
logist
regress
linkag
disequilibrium
studi
show
allel
close
relat
suscept
sever
sepsi
poor
outcom
sever
septic
patient
haplotyp
even
poorer
outcom
individu
haplotyp
less
suscept
sever
sepsi
reason
correl
occurr
outcom
sever
sepsi
may
attribut
follow
point
locat
untransl
region
polymorph
may
result
chang
space
conform
mrna
would
alter
stabil
mrna
effici
translat
impact
protein
function
signific
nonsynonym
snp
code
region
quantiti
protein
would
chang
dramat
howev
genet
associ
analysi
may
surfac
marker
unknown
real
genet
marker
sepsi
linkag
disequilibrium
although
hypothesi
need
prove
research
abovement
studi
indic
might
influenti
factor
process
immun
defens
inflamm
regul
sepsi
locu
may
import
genet
warn
indic
suscept
sever
sepsi
outcom
copi
number
variat
cnv
kind
genet
polymorph
account
approxim
human
genom
dna
refer
largescal
duplic
delet
certain
dna
section
caus
variat
number
copi
one
gene
previou
public
report
cnv
present
gene
gene
gene
gene
gene
copi
number
posit
correl
mrna
level
recent
chen
et
al
screen
sever
sepsi
healthi
control
averag
copi
number
per
genom
observ
studi
popul
rang
author
found
patient
high
copi
number
predispos
sever
sepsi
tend
lower
level
plasma
well
cytokin
valid
find
independ
cohort
result
indic
cnv
defensin
gene
may
potenti
genet
marker
identifi
high
risk
patient
provid
individu
treatment
sepsi
defensin
emerg
therapeut
molecul
pathogen
sepsi
broad
spectrum
antimicrobi
properti
past
decad
two
number
potent
salt
insensit
defensin
analog
screen
structur
modifi
synthes
howev
studi
perform
vitro
much
known
vivo
role
molecul
fact
chemoattract
immunomodul
effect
make
defensin
doubleedg
sword
pathogenesi
sepsi
lead
facilit
pathogen
clearanc
well
exacerb
inflamm
injuri
selftissu
recent
sever
investig
show
chemoattract
antimicrobi
activ
defensin
could
separ
shed
light
design
defensinderiv
pharmaceut
addit
genet
studi
help
identifi
high
risk
patient
suscept
sepsi
advers
outcom
provid
foundat
futur
individu
sepsi
treatment
target
defensin
